| HOME >> BIOLOGY >> TECHNOLOGY |
Table 6-3 Leading Biotech Therapies by 2010 Revenues
Table 6-4 Global Biopharmaceutical Treatments (non-vaccine)Market Forecast by Product Category, 2010 and 2015—based on late stage development
Figure 6-3 Global Biopharmaceutical Treatments (non-vaccine)Market Forecast by Product Category, 2010 and 2015—based on late stage development
Table 6-5 Biopharmaceutical Treatments (non-vaccine)Sales by Region, 2008-2010 and Forecast through 2015
Figure 6-4 Biopharmaceutical Treatments (non-vaccine)Sales by Region, 2008-2010 and Forecast through 2015
Figure 6-5 Estimated Biopharmaceutical Treatments (non-vaccine)Sales by Broad Region, 2010
Table 6-6 Competitor Market Shares and Revenues for Biopharmaceutical Therapies, 2010
Figure 6-6 Biopharmaceutical Sales by Company, 2008-2010
Figure 6-7 Competitor Market Shares for Biopharmaceutical Therapies, 2010
Table 6-7 Top Three Competitors for Autoimmune Biopharmaceutical Treatments, 2010
Figure 6-8 Competitor Market Shares: Autoimmune Biopharmaceutical Therapies, 2010
Table 6-8 Top Three Competitors for Cancer Biopharmaceutical Treatments, 2010
Figure 6-9 Competitor Market Shares: Cancer Biopharmaceutical Treatments, 2010
Table 6-9 Top Three Competitors for Cardiovascular/Blood Disorder Biopharmaceutical Treatments, 2010
Figure 6-10 Competitor Market Shares: Cardiovascular/Blood Disorder Biopharmaceutical Treatments, 2010
Table 6-10 Top Three Competitors for Hormone Biopharmaceutical Treatments, 2010
Figure 6-11 Competitor Market Shares: Hormone Biopharmaceutical Treatments, 2010
To order this report:
Biopharmaceutical Industry: What%s Next in Biologics?
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |